Skip to main content
ACON
NASDAQ Life Sciences

Aclarion的Nociscan AI技术获得Pinnacle创新奖

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
7
Price
$3.15
Mkt Cap
$7.326M
52W Low
$2.34
52W High
$12.03
Market data snapshot near publication time

summarizeSummary

Aclarion, Inc.宣布其获得了临床决策AI类别的钻石Pinnacle奖，原因是其Nociscan解决方案在AI创新方面的贡献。这一认可验证了公司专有的增强智能算法，它们帮助医生识别慢性下背痛的位置。对于一家小盘公司来说，这个外部奖项提供了显著的可信度和动力，建立在最近The London Clinic采用Nociscan的消息之上。这一积极的发展可能会增强投资者信心，并可能有助于在更广泛的市场中采用。交易者将监测进一步的商业里程碑和临床验证。

在该公告发布时，ACON的交易价格为$3.15，交易所为NASDAQ，所属行业为Life Sciences，市值约为$732.6万。 52周交易区间为$2.34至$12.03。 这则新闻被评估为积极市场情绪，重要性评分为7/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed ACON - Latest Insights

ACON
Apr 27, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Aclarion Seeks Shareholder Approval for Significant Equity Plan Expansion, Authorizing 18.56% Potential Dilution
Sentiment: Negative
View Wiseek Article
ACON
Apr 22, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Aclarion Authorizes $2.5M Share Repurchase Program, Signaling Confidence
Sentiment: Positive
View Wiseek Article
ACON
Apr 16, 2026, 6:47 AM EDT
Source: GlobeNewswire
Importance Score:
8
Aclarion Secures Key U.S. Patent for AI-Driven Chronic Back Pain Assessment Platform
Sentiment: Positive
View Wiseek Article
ACON
Apr 14, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Aclarion's Nociscan AI Technology Wins Pinnacle Award for Innovation
Sentiment: Positive
View Wiseek Article
ACON
Apr 07, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Aclarion's Nociscan Nears 100 Scans at London Clinic, Signaling Growing Adoption
Sentiment: Positive
View Wiseek Article
ACON
Apr 03, 2026, 5:02 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Aclarion Seeks Shareholder Approval for Major Equity Plan Expansion and Re-election of Contested Director
Sentiment: Negative
View Wiseek Article
ACON
Mar 24, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
8
Activist Investor Demands Board Member Resignation at Aclarion Amid 99% Stock Decline
Sentiment: Negative
View Wiseek Article
ACON
Mar 19, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Aclarion Adopts 'Poison Pill' Stockholder Rights Plan to Deter Hostile Takeovers
Sentiment: Negative
View Wiseek Article
ACON
Jan 13, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
9
Aclarion Secures $10.4M Financing at Premium, Extends Cash Runway into 2028
Sentiment: Positive
View Wiseek Article
ACON
Jan 09, 2026, 9:03 AM EST
Filing Type: 8-K
Importance Score:
9
Aclarion to Raise $10.36M in Highly Dilutive Offering at Deep Discount
Sentiment: Negative
View Wiseek Article